[ET Net News Agency, 16 May 2018] China Resources Pharmaceutical (03320) said it is in
discussion with the People's Government of Jiangxi Province of the proposed formation of a
strategic cooperation framework agreement to establish long-term strategic cooperation
relationship.
As part of the strategic cooperation, China Resources Pharmaceutical and Jiangxi
Government contemplate to restructure Jiangxi Jiangzhong Pharmaceutical (Group) Co, Ltd.
whereby China Resources Pharmaceutical will acquire the controlling stake in Jiangzhong
Group.
Jiangzhong Group is a large-scale pharmaceutical enterprise specialized in traditional
Chinese medicine. Jiangzhong Group controls 43.03% shareholding interest in Jiangzhong
Pharmaceutical, a pharmaceutical company listed on the Shanghai Stock Exchange (stock
code: 600750). Jiangzhong Group is indirectly owned by the State-owned Assets Supervision
and Administration Commission of Jiangxi Provincial Government as to 41.54% of its equity
interest. (HL)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03320 CHINARES PHARMA
Nominal 
5.220 +0.070 (+1.359%) Others
16/05/2018 09:08
CR Pharma may buy controlling stake in Jiangzhong Group
| Remark: | Real time quote last updated: 26/09/2024 10:34 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |